Publication Date
12-9-2025
Journal
Trials
DOI
10.1186/s13063-025-09268-w
PMID
41366462
PMCID
PMC12690913
PubMedCentral® Full Text Version
Post-print
Abstract
Background: Aggressive treatment with multimodal therapies such as surgery, chemotherapy, and radiation therapy has improved survival in head and neck cancer (HNC) but at a human cost of a substantial symptom burden and impact on quality of life. We developed the NYU Electronic Patient Visit Assessment (ePVA)© for HNC as a digital patient-reported symptom monitoring system that enables early symptom detection and real-time interventions at the point of care. With this study protocol, we aim to test the effectiveness of the ePVA in improving HNC outcomes in real-world settings and to identify implementation strategies optimizing its effectiveness.
Methods: We will conduct a longitudinal mixed-methods hybrid type I study at four National Cancer Institute-designated Comprehensive Cancer Centers serving diverse populations in rural and urban settings (New York University, the University of Kansas Cancer Center, Fox Chase Cancer Center, and Baylor College of Medicine) guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Patient eligibility criteria include having histologically diagnosed HNC and undergoing radiation therapy with or without chemotherapy for curative intent. We will also interview clinicians caring for patients with HNC at the participating institutions regarding facilitators and barriers to implementing the ePVA. The accrual goal is 270 patients. Aim 1 is to determine the effect of the ePVA on HNC symptoms in a two-arm (usual care vs. ePVA + usual care) trial. The study's primary outcomes are patients' self-reported social function, senses of taste and smell, and swallowing, measured by the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-H&N35. For Aim 2, we will interview patients (n = 40) as well as clinicians (n = 30) caring for patients with HNC at the participating institutions regarding facilitators and barriers to implementing the ePVA. In Aim 3, we will integrate Aims 1 and 2 data to identify strategies that optimize the use of the ePVA.
Discussion: The overarching goal of this research is to advance cancer care by identifying implementation standards for effective, widespread use of the ePVA that apply to all patient-reported outcomes in cancer care.
Keywords
Humans, Head and Neck Neoplasms, Patient Reported Outcome Measures, Multicenter Studies as Topic, Quality of Life, Longitudinal Studies, Urban Population, Rural Population, Treatment Outcome, Symptoms, Head and neck cancer, Digital, Patient-reported measures, Function, Clinical trial
Published Open-Access
yes
Recommended Citation
Van Cleave, Janet H; Brody, Abraham A; Schulman-Green, Dena; et al., "Implementing the NYU Electronic Patient Visit Assessment (ePVA)" (2025). Faculty, Staff and Students Publications. 6112.
https://digitalcommons.library.tmc.edu/baylor_docs/6112
Comments
Trial registration: ClinicalTrials.gov NCT06030011. Registered on 8 September 2023.